Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human TG/Thyroglobulin Antibody (SAA0534)

Catalog #:   RHB93301 Specific References (49) DATASHEET
Host species: Human
Isotype: VHH-hFc
Applications: ELISA, IF, IHC, RIA, SPR
Accession: P01266
Overview

Catalog No.

RHB93301

Species reactivity

Human

Host species

Human

Isotype

VHH-hFc

Clonality

Monoclonal

Target

Thyroglobulin, Tg, TG

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01266

Applications

ELISA, IF, IHC, RIA, SPR

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0534

Data Image
  • SDS-PAGE
    SDS PAGE for Anti-Human TG/Thyroglobulin Antibody (SAA0534)
References

Clinical Implications of Lymph Node Thyroglobulin in Papillary Thyroid Carcinoma Metastases: Independent from Thyroglobulin Antibody Interference., PMID:40508149

Study of the MTHFR 677C>T Polymorphism in Children and Adolescents with Hashimoto's Thyroiditis: An Original Case-Control Study., PMID:40506882

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica., PMID:40506785

Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Qualitative Patient and Clinician Interviews Informing the Development of a Conceptual Model., PMID:40506564

Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation., PMID:40506471

Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis., PMID:40504283

Undetectable Serum Thyroglobulin in Patients with Differentiated Thyroid Cancer: Anti-Thyroglobulin Antibodies, Assay Limitation, or Other?, PMID:40499758

Lecanemab Binds to Transgenic Mouse Model-Derived Amyloid-β Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds., PMID:40495448

Association analysis of polymorphisms in IL-5 and IL-9, with Allergic Asthma disease in Al-Diwaniyah City., PMID:40491234

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study., PMID:40473445

Comparison of Ultrasensitive and Highly Sensitive Assay to Predict Stimulated Thyroglobulin Levels Using Unstimulated Levels in Differentiated Thyroid Cancer Patients., PMID:40468888

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis., PMID:40467521

Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma., PMID:40467383

Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease., PMID:40461266

An Enhanced Diagnostic Model for Incidental Hashimoto's Thyroiditis Using T2-Weighted and Diffusion-Weighted Imaging., PMID:40450387

Etiologic Determinants and Characteristics of Diabetes in Haitian Youth (EDDHY Study)., PMID:40458319

Hashimoto's Encephalopathy With Progressive Cognitive Decline: A Rare Autoimmune Disorder in Central America., PMID:40453306

Care Coordination for Mosunetuzumab Therapy in Patients With Follicular Lymphoma in Community Practices: Learnings From the MorningSun Study Investigators., PMID:40432369

The Relationship Between Serum Levels of Thyroglobulin Antibody and the Risk of Recurrence in Patients With Differentiated Thyroid Cancer., PMID:40423684

Positive thyroid autoantibodies in primary Sjögren syndrome define a subset of patients with milder disease., PMID:40410650

In vitro effects of Mim8 and combined Mim8-bypassing therapy on thrombin generation, thromboelastography and fibrin clot ultrastructure., PMID:40398047

Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy., PMID:40382362

Report of Consensus Panel 5 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors., PMID:40379542

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25., PMID:40369344

Suppression of mechanical hypersensitivity and change in the expression of the dopamine D2 receptor by administration of anti-CGRP antibody into the trigeminal ganglion in trigeminal neuropathic pain model rats., PMID:40367052

Unveiling the Link Between Vitamin D, Hashimoto's Thyroiditis, and Thyroid Functions: A Retrospective Study., PMID:40362783

An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates., PMID:40360349

Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia., PMID:40359013

Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403., PMID:40355425

EXCALIBER-RRMM: a phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma., PMID:40346992

Impact of thyroglobulin changes on clinical outcomes of differentiated thyroid cancer with biochemical incomplete response., PMID:40346325

Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer., PMID:40346041

Clinical Features and Outcomes of Glutamic Acid Decarboxylase-65 Antibody-Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single-Center Cohort Study., PMID:40342250

Molecular sensitisation patterns to aeroallergens in a Mediterranean paediatric population and their clinical implications., PMID:40342116

Investigation of Eating Behaviors in Euthyroid Patients With Hashimoto's Thyroiditis., PMID:40337564

New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies., PMID:40332536

CD200R blockade enhances anti-tumor immunity by unleashing NK and CD8+ T cells in tumor., PMID:40329005

Core diagnostic features of stiff person syndrome: insights from a case-control study., PMID:40323494

Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE., PMID:40315644

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models., PMID:40312392

Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies., PMID:40301559

Over-expression of Truncated IK Ameliorates Dinitrochlorobenzene-Induced Allergic Contact Dermatitis Lesions in BALB/c Mice., PMID:40294983

Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter study., PMID:40288332

Effects of dietary supplementation with Laurus nobilis extract on growth performance, carcass features, blood lipid profile, immunity, antioxidative status, digestive enzymes, and gut microbial load in growing New Zealand white rabbits., PMID:40272631

Risk prediction for recurrent pregnancy loss based on routine inspections in the first trimester of pregnancy, a retrospective study in China., PMID:40270497

FNA-Tg improves the diagnostic efficacy of FNAC for PTC lateral cervical LN metastasis., PMID:40269136

Clinical characteristics of dry eye patients with thyroid disorders: a cross-sectional study., PMID:40264022

Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study., PMID:40260947

Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series., PMID:40255393

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TG/Thyroglobulin Antibody (SAA0534) [RHB93301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only